Connect your AI

VWAV VWAV Change In Fair Value Of Convertible Notes Payable

Change In Fair Value Of Convertible Notes Payable at other companies

Jade Biosciences, Inc. Common StockJBIO

$0-100%

VisionWave Holdings, Inc. Common StockVWAV

$36.84K—

NioCorp Developments Ltd.NB

$10K-98.4%

Jade Biosciences, Inc. Common StockJBIO

$0-100%

GCT

GCT Semiconductor HoldingGCTS

$1.29M+6,668%

ASP Isotopes, Inc.ASPI

-$568K+40.6%

Other financials

Income statement

Revenue$10.0M—

Operating income-$11.1M-7,634%

Net income-$12.9M-44,661%

EPS (diluted)-$0.66—

Balance sheet

Cash & equivalents$14.3M+23,310%

Total equity$98.6M+32,583%

Total assets$135.7M—

Cash flow

Operating cash flow-$3.4M-1,952%

Valuation

Market cap$110.62M+226%

Returns & leverage

Return on equity-52.8%—

Current ratio0.4×—

Where this comes from

Reported directly by VWAV in its filing.

Tagged under the XBRL concept VWAV:ChangeInFairValueOfConvertibleNotesPayable.

The official record: VWAV’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about VWAV's change in fair value of convertible notes payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is VWAV's change in fair value of convertible notes payable?: VWAV (VWAV) reported change in fair value of convertible notes payable of -$7.63K in Q1 2026.